Ausgabe 1/2019
Inhalt (13 Artikel)
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
Markus Kieler, Matthias Unseld, Johann Wojta, Alexandra Kaider, Daniela Bianconi, Svitlana Demyanets, Gerald W. Prager
The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target
Lydia Brandl, Nina Kirstein, Jens Neumann, Andrea Sendelhofert, Michael Vieth, Thomas Kirchner, Antje Menssen
Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis
Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama
Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama
The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma
Alexandre A. B. A. da Costa, Felipe D’Almeida Costa, Daniel Vilarim Araújo, Marcos Pedro Guedes Camandaroba, Victor Hugo Fonseca de Jesus, Audrey Oliveira, Ana Caroline Fonseca Alves, Carlos Stecca, Larissa Machado, Andrea Cruz Feraz de Oliveira, Thiago Bueno de Oliveira, Ulisses Ribaldo Nicolau, Vladmir Cláudio Cordeiro de Lima
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer
B. A. Jereczek-Fossa, A. Maucieri, G. Marvaso, S. Gandini, C. Fodor, D. Zerini, G. Riva, O. Alessandro, A. Surgo, S. Volpe, G. Fanetti, S. Arculeo, M. A. Zerella, S. Parisi, P. Maisonneuve, A. Vavassori, F. Cattani, R. Cambria, C. Garibaldi, A. Starzyńska, G. Musi, O. De Cobelli, M. Ferro, F. Nolè, D. Ciardo, R. Orecchia
Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma
Keisuke Miyake, Yoshifumi Baba, Takatsugu Ishimoto, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yuji Miyamoto, Naoya Yoshida, Masayuki Watanabe, Yoko Ogata, Megumi Nagayama, Atit Silsirivanit, Daiki Kobayashi, Norie Araki, Hideo Baba
IL-39 acts as a friend to pancreatic cancer
Alicia A. Manning, Lei Zhao, Ziwen Zhu, Huaping Xiao, Chase G. Redington, Vivi A. Ding, Theodore Stewart-Hester, Qian Bai, Jacob Dunlap, Mark R. Wakefield, Yujiang Fang
Multidisciplinary team in head and neck cancer: a management model
F. De Felice, V. Tombolini, M. de Vincentiis, G. Magliulo, A. Greco, V. Valentini, A. Polimeni
Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia
Luma Dayane de Carvalho Filiú-Braga, Teresa Raquel Tavares Serejo, Antonio Roberto Lucena-Araujo, Francisco Assis Rocha Neves, Juliana Lott de Carvalho, Eduardo Magalhaes Rego, Felipe Saldanha-Araujo
Radiotherapy with the anti-programmed cell death ligand-1 immune checkpoint blocker avelumab: acute toxicities in triple-negative breast cancer
Eliana La Rocca, Michela Dispinzieri, Laura Lozza, Gabriella Mariani, Serena Di Cosimo, Massimiliano Gennaro, Riccardo Valdagni, Maria Carmen De Santis
Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study
J. E. Freund, E. I. M. L. Liem, C. D. Savci-Heijink, T. M. de Reijke
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient’s care behalf the CANCERVIH Group
Aurelien Gobert, Jean-Philippe Spano, Jacques Cadranel